To date the medical cannabis market has been dominated by suppliers extracting cannabinoids from hemp. Farmers globally are switching food crops to hemp which is having significant impact on environment and global food supplies. Our plan allows us to produce nature identical cannabinoids using organic chemistry methods, or using a proprietary eco-friendly biological technology, and not requiring us to grow plants at all.
There are significant benefits to using our methods, including lower financial cost and environmental impact.
We aim to be the world’s largest supplier of generic pharmaceutical grade Cannabinoids (such as CBD, CBG, THCV etc). Using our patented organic chemistry, and cutting edge biological production methods we will produce generic, rare and novel cannabinoids more economically than can be done with traditional farming methods, with standardised purity and with less environmental impact.